EUVC podcast

Andreas Cleve (Corti): Why constraints can be an advantage in vertical AI

30.10.2026
0:00
50:28
15 Sekunden vorwärts
15 Sekunden vorwärts

In vertical AI, choosing a narrower market can look like giving up scale, but for Corti it created the focus needed to go much deeper into healthcare and build around the accuracy, compliance and real-world complexity that clinical environments demand.

Andreas Cleve, Co-Founder and CEO of Corti, joins us to explain the thinking behind that choice and what it has meant in practice.

Andreas describes healthcare not as one market but as many highly specialised ones, each with its own workflows, terminology and requirements.

That depth means bigger general-purpose models alone are not enough. Corti has instead had to build further down the stack and take greater control over the technology and infrastructure required to get AI into production.

The trade-off becomes especially clear around accuracy. AI can perform well in a demo and still fall short in a clinical environment, where one incorrect word or detail can change the meaning entirely.

Andreas explains why clinical-grade performance depends on much more than training better models, from working closely with users to adapting to individual specialties and solving the last-mile problems that appear when technology meets real workflows.

The conversation also explores why Corti brought compliance in-house rather than treating regulation as something to outsource.

For founders building in healthcare, legal, financial services or other high-stakes domains, the broader question is how to decide which constraints to accept, which capabilities to own and where going deeper can create an advantage that broader competitors struggle to replicate.

Highlights

  • Why Corti chose vertical AI over a broader horizontal approach
  • What founders give up when they deliberately narrow their market
  • Why bigger models do not automatically solve regulated-domain problems
  • Why 90% accuracy can still fall far short in clinical environments
  • How specialisation pushes vertical AI companies deeper into the stack
  • Why getting AI into production requires more than model performance
  • Why Corti built its compliance capability in-house
  • How founders can think differently about regulation and other high-stakes constraints


Timestamps

  • (00:00) Intro
  • (01:45) What Corti is building
  • (03:45) Why healthcare needs specialised AI
  • (05:45) Why bigger models do not solve healthcare
  • (07:40) Healthcare is not one market
  • (09:50) The trade-offs of going vertical
  • (11:50) Funding a capital-intensive AI company from Europe
  • (13:15) Why Corti is doubling down on Copenhagen
  • (16:45) Copenhagen’s talent problem
  • (19:30) Why 90% accuracy is not enough in healthcare
  • (23:00) Solving the last mile of healthcare AI
  • (25:45) Where AI adoption is happening fastest in healthcare
  • (31:20) Why regulation is not the enemy
  • (34:40) How founders should approach compliance
  • (37:40) What founders should understand about venture funding
  • (42:30) Why European VCs need a GPU strategy
  • (46:40) Europe’s growth funding gap
  • (48:00) When should European founders move to the US?

Weitere Episoden von „EUVC“